MYC and neoplasm: Furthermore, we used immunohistochemistry (IHC) to confirm the expression of c‐Myc and caspase‐3, showing consistency with the scRNA data, and observed that both c‐Myc and caspase‐3 were highly expressed in late‐stage tumours (Figure 2G).